Psoriasis treatment: Unconventional and non-standard modalities in the era of biologics

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 1

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Dermatology

ISSN

2218-6190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Dermatol. Feb 2, 2016; 5(1): 17-51
Published online Feb 2, 2016. doi: 10.5314/wjd.v5.i1.17

Table 3 Methotrexate drug interactions of significance

Interacting drug	Mechanism/comments
Drugs that increase methotrexate drug levels and toxicity
Salicylates	Decrease renal excretion, displacement from plasma proteins
NSAIDs	Decrease renal excretion, displacement from plasma proteins
Sulfonamides	Decrease renal excretion, displacement from plasma proteins
Dipyridamole	Increased intracellular accumulation of methotrexate
Probenecid	Increased intracellular accumulation of methotrexate, decreased renal tubular function
Chloramphenicol	Displacement from plasma proteins
Phenothiazines	Displacement from plasma proteins
Phenytoin	Displacement from plasma proteins
Tetracyclines	Displacement from plasma proteins
Drugs that simultaneously inhibit folate metabolic pathway-increase hematologic toxicity
Trimethoprim	Inhibition of dihyrofolate reductase
Sulfonamides	Inhibition of dihydropteroate synthetase
Dapsone	Inhibition of dihydropteroate synthetase
Drugs that may synergistically increase hepatotoxicity-common target organ
Systemic retinoids	Common target organ for toxicity-liver
Alcohol	Common target organ for toxicity-liver

NSAID: Nonsteroidal anti-inflammatory drug.

Citation: Mahajan VK. Psoriasis treatment: Unconventional and non-standard modalities in the era of biologics. World J Dermatol 2016; 5(1): 17-51
URL: https://www.wjgnet.com/2218-6190/full/v5/i1/17.htm
DOI: https://dx.doi.org/10.5314/wjd.v5.i1.17

Mahajan VK. Psoriasis treatment: Unconventional and non-standard modalities in the era of biologics. World J Dermatol 2016; 5(1): 17-51 [DOI: 10.5314/wjd.v5.i1.17]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.